Jinesh Gheeya, MD, PhD
@jinesh.bsky.social
Thoracic Medical Oncologist at the Ohio State University s/p University of Texas, Rutgers, NCI, UC Davis | Aspiring clinical trialist | Interested in developing novel immunotherapy and cell therapy in lung cancer #MedSky #OncSky #lcsm
Pinned
I have made a list of oncologists on BlueSky. This is certainly not exhaustive. Please comment below to be added to the list.
bsky.app/profile/did:...
bsky.app/profile/did:...
Reposted by Jinesh Gheeya, MD, PhD
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA
March 22, 2025 at 10:44 AM
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA
Reposted by Jinesh Gheeya, MD, PhD
Today I lost an NIH grant training clinicians to do research about intimate partner violence with perinatal women.
More women are murdered in the perinatal period than die of obstetric complications.
I didn't just lose a grant. We lost an entire cohort of people building careers to prevent that.
More women are murdered in the perinatal period than die of obstetric complications.
I didn't just lose a grant. We lost an entire cohort of people building careers to prevent that.
March 22, 2025 at 12:19 AM
Today I lost an NIH grant training clinicians to do research about intimate partner violence with perinatal women.
More women are murdered in the perinatal period than die of obstetric complications.
I didn't just lose a grant. We lost an entire cohort of people building careers to prevent that.
More women are murdered in the perinatal period than die of obstetric complications.
I didn't just lose a grant. We lost an entire cohort of people building careers to prevent that.
Reposted by Jinesh Gheeya, MD, PhD
🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
March 22, 2025 at 12:32 PM
🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
Reposted by Jinesh Gheeya, MD, PhD
The University of Sheffield, supported by the Ruth Strauss Foundation, is running an anonymous 30 min survey for people in the UK with non-smoking #lungcancer.
It aims to understand what information is most helpful & where support can be improved. #LCSM
👉 shef.qualtrics.com/jfe/form/SV_...
It aims to understand what information is most helpful & where support can be improved. #LCSM
👉 shef.qualtrics.com/jfe/form/SV_...
February 25, 2025 at 7:49 AM
The University of Sheffield, supported by the Ruth Strauss Foundation, is running an anonymous 30 min survey for people in the UK with non-smoking #lungcancer.
It aims to understand what information is most helpful & where support can be improved. #LCSM
👉 shef.qualtrics.com/jfe/form/SV_...
It aims to understand what information is most helpful & where support can be improved. #LCSM
👉 shef.qualtrics.com/jfe/form/SV_...
Reposted by Jinesh Gheeya, MD, PhD
Please enjoy my last ever post at Climate.gov/ENSO Blog. This afternoon I was fired by the Trump Administration 15 days before my 2yr probationary period ended on March 13.
I have worked at NOAA since 2010, and I'm so incredibly proud of the work I did. If anyone wants a quote, let me know.
I have worked at NOAA since 2010, and I'm so incredibly proud of the work I did. If anyone wants a quote, let me know.
Predicting El Niño and La Niña is tough, but new research analyzing 20+ years of forecasts finds dynamical models outperform statistical ones, especially for El Niño. La Niña onset? That's been much harder. Read more in our new ENSO blog post! www.climate.gov/news-feature...
February 27, 2025 at 11:22 PM
Please enjoy my last ever post at Climate.gov/ENSO Blog. This afternoon I was fired by the Trump Administration 15 days before my 2yr probationary period ended on March 13.
I have worked at NOAA since 2010, and I'm so incredibly proud of the work I did. If anyone wants a quote, let me know.
I have worked at NOAA since 2010, and I'm so incredibly proud of the work I did. If anyone wants a quote, let me know.
Reposted by Jinesh Gheeya, MD, PhD
The #HPV vaccine has decreased high grade cervical dysplasia in the USA by 80 % in the youngest age group. Reported in today's MMWR.
#MedSky + #ObGynSky.
www.cdc.gov/mmwr/volumes...
#MedSky + #ObGynSky.
www.cdc.gov/mmwr/volumes...
Trends in Cervical Precancers Identified ...
This report describes decreases in cervical precancer incidence among women ages 20-24 years.
www.cdc.gov
February 27, 2025 at 11:36 PM
The #HPV vaccine has decreased high grade cervical dysplasia in the USA by 80 % in the youngest age group. Reported in today's MMWR.
#MedSky + #ObGynSky.
www.cdc.gov/mmwr/volumes...
#MedSky + #ObGynSky.
www.cdc.gov/mmwr/volumes...
Reposted by Jinesh Gheeya, MD, PhD
🔥@cellpress.bsky.social Trends in Cancer🆙
✅KRAS inhibitors: resistance drivers and combinatorial strategies
🎯Progress on defining resistance mechanisms and developing combination treatment strategies
👥Dr. Tamara Isermann
#LCSM @oncoalert.bsky.social #KRAS
www.cell.com/trends/cance...
✅KRAS inhibitors: resistance drivers and combinatorial strategies
🎯Progress on defining resistance mechanisms and developing combination treatment strategies
👥Dr. Tamara Isermann
#LCSM @oncoalert.bsky.social #KRAS
www.cell.com/trends/cance...
KRAS inhibitors: resistance drivers and combinatorial strategies
In 1982, the RAS genes HRAS and KRAS were discovered as the first human cancer genes,
with KRAS later identified as one of the most frequently mutated oncogenes. Yet, it
took nearly 40 years to develo...
www.cell.com
January 20, 2025 at 1:25 PM
🔥@cellpress.bsky.social Trends in Cancer🆙
✅KRAS inhibitors: resistance drivers and combinatorial strategies
🎯Progress on defining resistance mechanisms and developing combination treatment strategies
👥Dr. Tamara Isermann
#LCSM @oncoalert.bsky.social #KRAS
www.cell.com/trends/cance...
✅KRAS inhibitors: resistance drivers and combinatorial strategies
🎯Progress on defining resistance mechanisms and developing combination treatment strategies
👥Dr. Tamara Isermann
#LCSM @oncoalert.bsky.social #KRAS
www.cell.com/trends/cance...
Reposted by Jinesh Gheeya, MD, PhD
Tables and Tornadoes: The Best Tools for the Job?
Tables (sometimes BIG) are among most routinely used tools to show data like baseline characteristics & AEs, while “tornado plots” are a standard figure to display AEs & sometimes other variables.
But could we do better, esp for live talks? (1/8)
Tables (sometimes BIG) are among most routinely used tools to show data like baseline characteristics & AEs, while “tornado plots” are a standard figure to display AEs & sometimes other variables.
But could we do better, esp for live talks? (1/8)
December 4, 2024 at 11:14 PM
Tables and Tornadoes: The Best Tools for the Job?
Tables (sometimes BIG) are among most routinely used tools to show data like baseline characteristics & AEs, while “tornado plots” are a standard figure to display AEs & sometimes other variables.
But could we do better, esp for live talks? (1/8)
Tables (sometimes BIG) are among most routinely used tools to show data like baseline characteristics & AEs, while “tornado plots” are a standard figure to display AEs & sometimes other variables.
But could we do better, esp for live talks? (1/8)
Reposted by Jinesh Gheeya, MD, PhD
Skytorial: Five pearls on olanzapine 😁
Between agitation and nausea/vomiting, olanzapine has a wide range of use.
Olanzapine is generally not a front-line agent (e.g., haloperidol or ondansetron often are). But sometimes, it really comes in clutch....
Between agitation and nausea/vomiting, olanzapine has a wide range of use.
Olanzapine is generally not a front-line agent (e.g., haloperidol or ondansetron often are). But sometimes, it really comes in clutch....
a man in a plaid shirt sits at a picnic table with the words " settle down " on the bottom
ALT: a man in a plaid shirt sits at a picnic table with the words " settle down " on the bottom
media.tenor.com
November 27, 2024 at 1:17 PM
Skytorial: Five pearls on olanzapine 😁
Between agitation and nausea/vomiting, olanzapine has a wide range of use.
Olanzapine is generally not a front-line agent (e.g., haloperidol or ondansetron often are). But sometimes, it really comes in clutch....
Between agitation and nausea/vomiting, olanzapine has a wide range of use.
Olanzapine is generally not a front-line agent (e.g., haloperidol or ondansetron often are). But sometimes, it really comes in clutch....
Reposted by Jinesh Gheeya, MD, PhD
⭐️Development and phenotype of regulatory T cells
This picture is worth 100 K words!
Link to pdf: www.stemcell.com/media/files/...
This picture is worth 100 K words!
Link to pdf: www.stemcell.com/media/files/...
November 24, 2024 at 10:44 PM
⭐️Development and phenotype of regulatory T cells
This picture is worth 100 K words!
Link to pdf: www.stemcell.com/media/files/...
This picture is worth 100 K words!
Link to pdf: www.stemcell.com/media/files/...
Reposted by Jinesh Gheeya, MD, PhD
We’re not going back.
November 24, 2024 at 10:07 PM
We’re not going back.
Reposted by Jinesh Gheeya, MD, PhD
A #ScienceImmunology review from earlier this year by @kuchroolab.bsky.social and co-authors discusses emerging roles of TIM-3 in immune responses including in #myeloidcells. #WeekendReads
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
We provide a comprehensive review of 20 years of research on TIM-3 functions in myeloid cells and T cell exhaustion.
www.science.org
November 24, 2024 at 4:59 PM
A #ScienceImmunology review from earlier this year by @kuchroolab.bsky.social and co-authors discusses emerging roles of TIM-3 in immune responses including in #myeloidcells. #WeekendReads
Reposted by Jinesh Gheeya, MD, PhD
Ok! Here’s a step-by-step instruction for @labels.medsky.social!
1. SUBSCRIBE to the labeler (and hit the like button while you’re at it)
2. LEAVE THE BADGES ON! (That’s how you see other specialties)
3. OPEN the labeler thread and find your specialty
4. LIKE the post with your specialty
5. VOILA!
1. SUBSCRIBE to the labeler (and hit the like button while you’re at it)
2. LEAVE THE BADGES ON! (That’s how you see other specialties)
3. OPEN the labeler thread and find your specialty
4. LIKE the post with your specialty
5. VOILA!
October 11, 2024 at 3:44 AM
Ok! Here’s a step-by-step instruction for @labels.medsky.social!
1. SUBSCRIBE to the labeler (and hit the like button while you’re at it)
2. LEAVE THE BADGES ON! (That’s how you see other specialties)
3. OPEN the labeler thread and find your specialty
4. LIKE the post with your specialty
5. VOILA!
1. SUBSCRIBE to the labeler (and hit the like button while you’re at it)
2. LEAVE THE BADGES ON! (That’s how you see other specialties)
3. OPEN the labeler thread and find your specialty
4. LIKE the post with your specialty
5. VOILA!
Summary table of key trials in metastatic NSCLC
November 24, 2024 at 8:39 PM
Summary table of key trials in metastatic NSCLC
This is fantastic. Table is very useful in framing GOC conversations
Is sharing our writing a thing here? 😊
Proud of this piece because it represents the work of so many trying to make medicine and communication better for our patients. #MedSky
www.mayoclinicproceedings.org/action/showP...
Proud of this piece because it represents the work of so many trying to make medicine and communication better for our patients. #MedSky
www.mayoclinicproceedings.org/action/showP...
November 23, 2024 at 9:15 PM
This is fantastic. Table is very useful in framing GOC conversations
Reposted by Jinesh Gheeya, MD, PhD
Great analysis of DLL3 expression in SCLC and difficult to treat neuroendocrine neoplasms. Excited to see more biomarker driven approaches to advance care in such needed spaces.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms - npj Precision Oncology
npj Precision Oncology - Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
www.nature.com
November 20, 2024 at 1:00 AM
Great analysis of DLL3 expression in SCLC and difficult to treat neuroendocrine neoplasms. Excited to see more biomarker driven approaches to advance care in such needed spaces.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Jinesh Gheeya, MD, PhD
Hello Bluesky! I’m a Professor at Fred Hutch and our lab studies the biology of small cell lung cancer. Using mouse and PDX models, cell-based and in vivo genetic screens, and genomic approaches, we seek to understand biologically distinct subsets of SCLC and their therapeutic vulnerabilities.
November 17, 2024 at 7:04 PM
Hello Bluesky! I’m a Professor at Fred Hutch and our lab studies the biology of small cell lung cancer. Using mouse and PDX models, cell-based and in vivo genetic screens, and genomic approaches, we seek to understand biologically distinct subsets of SCLC and their therapeutic vulnerabilities.
Reposted by Jinesh Gheeya, MD, PhD
Reposted by Jinesh Gheeya, MD, PhD
Dr. @rielymd.bsky.social addresses waiting for biomarkers in the treatment of NSCLC at #NYLung24. Can be hard to be patient but critically important to avoid giving the wrong treatment. Sequence of treatments have consequences. #LCSM #OncSky #MedSky
November 16, 2024 at 6:33 PM
Dr. @rielymd.bsky.social addresses waiting for biomarkers in the treatment of NSCLC at #NYLung24. Can be hard to be patient but critically important to avoid giving the wrong treatment. Sequence of treatments have consequences. #LCSM #OncSky #MedSky
Reposted by Jinesh Gheeya, MD, PhD
Recommend this excellent review from @BCJoyceO and co
“Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach” #MedTwitter #bcsm ascopubs.org/doi/abs/10.1...
“Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach” #MedTwitter #bcsm ascopubs.org/doi/abs/10.1...
Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach | JCO Oncology Practice
Circulating tumor DNA (ctDNA) refers to DNA fragments released from cancer cells into
the bloodstream. Clinical utility of ctDNA in breast cancer has been explored in both
metastatic breast cancer (MB...
ascopubs.org
November 16, 2024 at 11:19 AM
Recommend this excellent review from @BCJoyceO and co
“Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach” #MedTwitter #bcsm ascopubs.org/doi/abs/10.1...
“Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach” #MedTwitter #bcsm ascopubs.org/doi/abs/10.1...
I have made a list of oncologists on BlueSky. This is certainly not exhaustive. Please comment below to be added to the list.
bsky.app/profile/did:...
bsky.app/profile/did:...
November 16, 2024 at 5:59 PM
I have made a list of oncologists on BlueSky. This is certainly not exhaustive. Please comment below to be added to the list.
bsky.app/profile/did:...
bsky.app/profile/did:...
With the new influx of folks on this app from the other site…my followers count has increased. So now I’m have to change from posting snarky comments to professionalish comments. I need a fakesky account for my snarky and salty musings.
November 15, 2024 at 5:24 AM
With the new influx of folks on this app from the other site…my followers count has increased. So now I’m have to change from posting snarky comments to professionalish comments. I need a fakesky account for my snarky and salty musings.
Reposted by Jinesh Gheeya, MD, PhD
I made a #LCSM list, small but growing! Not sure how to make it public? bsky.app/profile/did:...
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
November 10, 2024 at 7:32 PM
I made a #LCSM list, small but growing! Not sure how to make it public? bsky.app/profile/did:...
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
